Relay Therapeutics, Inc.

Historical 13F Holders

Symbol
RLAY
CUSIP
75943R102
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 75943R102 since 12/18/2024, largest first.

Filer % of Class Filed
FMR LLC 13G/A
10.0% 8/7/2026
Event 7/31/2026
SB Investment Advisers (UK) Ltd 13G/A
9.9% 11/16/2026
Event 9/30/2026
T. Rowe Price Investment Management, Inc. 13G 8.2% 11/16/2026
Event 9/30/2026
Casdin Capital, LLC 13G/A
7.5% 2/17/2026
Event 12/31/2025
Perceptive Advisors LLC 13G/A
6.4% 8/10/2026
Event 6/30/2026
BlackRock, Inc. 13G/A 6.1% 4/17/2025
Event 3/31/2025
Commodore Capital LP 13G/A
5.5% 8/14/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Point72 Asset Management, L.P. 13G/A
0% 5/15/2026
Event 3/31/2026
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 265 253 M $4.57B
2026 Q2 265 247 M $4.58B
2026 Q1 247 185 M $1.84B
2025 Q4 230 174 M $1.47B
2025 Q3 203 167 M $872M
2025 Q2 211 171 M $592M
2025 Q1 210 167 M $439M
2024 Q4 202 164 M $676M
2024 Q3 197 163 M $1.16B
2024 Q2 180 127 M $827M
2024 Q1 190 132 M $1.10B
2023 Q4 178 127 M $1.40B
2023 Q3 173 130 M $1.10B
2023 Q2 163 130 M $1.64B
2023 Q1 159 131 M $2.16B
2022 Q4 167 128 M $1.91B
2022 Q3 164 123 M $2.76B
2022 Q2 150 121 M $2.02B
2022 Q1 142 113 M $3.38B
2021 Q4 132 111 M $3.41B
2021 Q3 137 91.8 M $2.89B
2021 Q2 126 89.1 M $3.26B
2021 Q1 138 85.6 M $2.96B
2020 Q4 116 87.7 M $3.64B
2020 Q3 95 90.3 M $3.64B